Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

New drug shows promise for better hair growth in baldness treatment.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Spironolactone effectively treats female pattern hair loss with few side effects.

Treat pattern hair loss with finasteride and topical minoxidil.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Oral contraceptives can effectively treat acne by reducing oil production.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.